Pharma & drug development · Reference
What is bioavailability?
Bioavailability is the fraction of an administered dose of a drug that reaches the systemic circulation in an active form. It is a key pharmacokinetic concept, and is described as either absolute or relative depending on the comparison made.
What bioavailability measures
Bioavailability captures how much of a dose actually becomes available to act in the body, and how quickly. When a drug is given directly into the bloodstream, all of it reaches the circulation, so its bioavailability is complete. When given by other routes — for example by mouth — only part of the dose may reach the circulation, because some can be lost to incomplete absorption or broken down before it gets there. Bioavailability is therefore a direct consequence of the ADME processes studied in pharmacokinetics, and it strongly influences how much drug exposure a given dose produces.
Absolute versus relative bioavailability
Bioavailability is described in two ways. Absolute bioavailability compares the exposure from a route of interest with the exposure from an intravenous dose, which represents complete availability — it answers “what fraction of this dose reached the circulation compared with injecting it directly?”. Relative bioavailability compares one formulation or route with another non-intravenous reference, for example comparing two oral products. Relative bioavailability is central to bioequivalence studies, which assess whether a generic product delivers the drug comparably to an established reference product.
Why bioavailability matters
Bioavailability is important throughout drug development because it links a dose to the exposure that ultimately drives effect. A candidate with poor oral bioavailability may need a different formulation or route, and such issues are often addressed during lead optimisation. Bioavailability is also why the same drug can behave differently when given in different forms.
In regulation, bioequivalence based on relative bioavailability is how generic medicines demonstrate they are interchangeable with a reference product. As a concept, bioavailability describes drug exposure for research and educational purposes and is not a basis for personal dosing decisions.
Key facts
At a glance
- Definition: Fraction of a dose reaching the circulation, active
- Reference: Intravenous dose = complete (100%) availability
- Absolute: Compared with an intravenous dose
- Relative: Compared with another non-IV formulation
- Bioequivalence: Uses relative bioavailability for generics
- Driven by: Absorption and first-pass metabolism (ADME)
Common questions
FAQ
What is bioavailability?+
Bioavailability is the fraction of an administered dose of a drug that reaches the bloodstream in an active form, and how fast it does so. A drug given intravenously is completely bioavailable; other routes deliver only part of the dose. It is a research and educational pharmacokinetic concept, not dosing advice.
What is the difference between absolute and relative bioavailability?+
Absolute bioavailability compares a route of administration with an intravenous dose, which represents complete availability, while relative bioavailability compares one non-intravenous formulation or route with another. Relative bioavailability is used in bioequivalence assessment.
Why does oral bioavailability vary?+
Oral bioavailability can be reduced because a drug is incompletely absorbed from the gut or is partly broken down before reaching the general circulation. These effects, part of ADME, mean an oral dose often delivers less drug to the bloodstream than an injected one.
The step most authors miss
Doing CRediT right? Don’t stop at the statement.
A CRediT statement credits you inside one paper. The recognition CRediT was built for happens when those roles are tied to you, persistently. Sign in with your ORCID — free — and claim your CRediT contributions on casrai.org, the home of the standard. They become a verified, portable part of your identity, not a line that disappears into one PDF.
Free: claim your contributions, then export a journal-ready CRediT statement, schema.org structured data, JATS XML, CSV or BibTeX — and preview your public profile. A membership publishes that profile publicly and verifies the journals you serve.
